Cognitive Training + tDCS for Depression

SS
Overseen BySarah Szymkowicz, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt University Medical Center
Must be taking: Antidepressants
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores non-drug treatments to determine their effectiveness in improving memory, thinking, and brain function in older adults with recurrent depression. It employs transcranial direct current stimulation (tDCS), which applies small electrical currents to the forehead, and computerized cognitive training, involving tablet games to boost brain activity. Participants will be divided into three groups, each experiencing different combinations of these treatments, including Depression Cognitive Training. The trial seeks participants who have had multiple episodes of depression and face challenges with planning, organization, or attention in daily life. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance non-drug treatment options for depression.

Will I have to stop taking my current medications?

You may need to stop taking certain medications that interfere with the brain stimulation part of the study, like sodium channel blockers or specific drugs affecting brain chemicals. If you're on antidepressants, you can continue them if they've been stable for at least 6 weeks.

What prior data suggests that these non-drug treatments are safe for older individuals with recurrent depression?

A previous study found that active transcranial direct current stimulation (tDCS) was safe and well-tolerated by participants. Over 80% of people found it comfortable, and no serious side effects were linked to the device. Research has shown that active tDCS can help reduce depression and anxiety symptoms in older adults, making it a promising treatment option.

No specific safety concerns have been reported for the depression cognitive training. This training uses games on a tablet to improve memory and thinking, which is generally considered safe and engaging.

Overall, both active tDCS and computerized cognitive training have demonstrated safety for older adults with depression.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for depression because they combine cognitive training with transcranial direct current stimulation (tDCS), offering a novel approach compared to traditional antidepressants and psychotherapy. Unlike standard treatments that often focus on chemical imbalances or involve talk therapy, this approach directly targets brain activity to potentially enhance cognitive functions and mood simultaneously. The use of active tDCS in combination with cognitive training is believed to improve the brain's plasticity, possibly leading to faster and more sustainable improvements in depressive symptoms.

What evidence suggests that this trial's treatments could be effective for depression?

Research has shown that active transcranial direct current stimulation (tDCS) can significantly reduce depression symptoms compared to inactive treatments. In this trial, one group will receive Depression Cognitive Training combined with active tDCS, which previous studies have demonstrated to have better antidepressant effects. Another group will receive Depression Cognitive Training with sham tDCS, while a third group will receive Non-Specific Cognitive Training with sham tDCS. Other research indicates that tDCS can also help reduce anxiety, particularly in those with mild depression. Additionally, combining tDCS with cognitive training has improved memory and thinking skills in some cases. Overall, these methods show promise for treating depression in older adults.14678

Are You a Good Fit for This Trial?

This trial is for people over 60 who have had at least two episodes of depression, are currently stable on antidepressants or not taking them, speak English, and have some trouble with memory or thinking. They must also have a recent history of depression diagnosed by a doctor.

Inclusion Criteria

* Presence of 2 or more lifetime depressive episodes to be considered "recurrent."
I have been on the same antidepressant for 6 weeks or am not taking any antidepressants.
* Fluent in English
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo daily cognitive training and tDCS sessions for 4 weeks

4 weeks
Daily visits (in-person)

Post-Intervention Assessment

Participants complete post-intervention evaluations including psychiatric and neuropsychological assessments

1-2 weeks

Follow-up

Participants are monitored for long-term effects on cognitive and brain function

3 months
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Depression Cognitive Training
  • Non-Specific Cognitive Training
  • tDCS (active stimulation)
  • tDCS (sham stimulation)

Trial Overview

The study tests if combining brain stimulation (tDCS) with computerized cognitive training helps improve memory and thinking in older adults with recurrent depression. Participants are randomly assigned to different combinations of these non-drug treatments.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Non-Specific Cognitive Training + Sham StimulationExperimental Treatment2 Interventions
Group II: Depression Cognitive Training + Sham StimulationExperimental Treatment2 Interventions
Group III: Depression Cognitive Training + Active StimulationExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University Medical Center

Lead Sponsor

Trials
922
Recruited
939,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Citations

Cognitive potency and safety of tDCS treatment for major ...

Results showed significant benefits following active tDCS compared to sham for the antidepressant effect [SMD: −0.77 (−1.44, −0.11)].

tDCS reduces depression and state anxiety symptoms in older ...

Active tDCS yielded greater reductions in depression and state anxiety than sham. •. These reductions were largest for those with mild ...

tDCS reduces depression and state anxiety symptoms in ...

Active tDCS yielded greater reductions in depression and state anxiety than sham. •. These reductions were largest for those with mild depression and moderate/ ...

Home-based transcranial direct current stimulation ...

In summary, a 10-week course of home-based active tDCS was associated with greater improvements in depressive symptoms, clinical response and ...

Transcranial Electrical Stimulation in Treatment of ...

Transcranial direct current stimulation and transcranial alternating current stimulation was associated with positive outcomes among patients with MDD and DPC ...

Efficacy and Safety of Transcranial Direct Current ...

Conclusions. These findings suggest that tDCS may be a promising nonpharmacological treatment option for depression in older adults, particularly in the context ...

Efficacy and safety of home-based transcranial direct ...

It was also indicated that, based on the HAM-D analysis on 438 patients, active tDCS showed a decrease in depression score compared to sham tDCS ...

Brain stimulation treatment may improve depression, ...

Brain stimulation treatment may improve depression, anxiety in older adults ... Dr. Adam Woods and a model participant demonstrate use of the tDCS ...